The 1 analysts offering 12-month price forecasts for Orgenesis Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +1,117.29% increase from the last price of 0.49.
The current consensus among 1 polled investment analysts is to Buy stock in Orgenesis Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.18
Reporting Date Mar 05
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.